Treatment of the patient’s gonococcal arthritis consists of line placement and six weeks of intravenous ceftriaxone 2 g daily, with weekly monitoring of complete blood count, complete metabolic panel, erythrocyte sedimentation rate, and C-reactive protein to monitor for improvement of signs of inflammation and infection [8]. Here, CRP is linked to gonococcal infection of joint.